Price:
Rs. 15,900.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: D0027
Frequently Asked Questions (FAQ's):
What does the DMD/BMD (79 Exons) test include?
This test screens all 79 exons of the dystrophin gene to identify deletions, duplications, or point mutations causing DMD and BMD.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated molecular techniques, such as multiplex PCR, MLPA, or NGS, to detect dystrophin gene mutations accurately.
Who should take this test?
Patients with clinical suspicion of DMD/BMD, family members for carrier testing, or individuals undergoing prenatal or preconception evaluation may be advised to take this test.
What sample type is required?
An EDTA anticoagulated blood sample is required for high-quality DNA extraction and precise molecular analysis.
Why is this test important?
Detecting dystrophin gene mutations helps confirm diagnosis, inform prognosis, guide treatment, and support genetic counseling for affected families.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows strict quality control, validated molecular protocols, and expert interpretation to ensure accurate and reproducible results.
Is any preparation needed before the test?
No special preparation or fasting is required; patients should follow physician instructions for sample collection.
How soon are results available?
Turnaround time may vary depending on test complexity, but Metropolis Healthcare provides timely and comprehensive reports to support clinical and genetic decision-making.